On 28 October 2026, a working meeting of the FIC Working Group on Healthcare and
Pharmaceutical Industry Development of the Foreign Investors’ Council under the
President of the Republic of Kazakhstan was held.
The
Kazakhstani side was represented by Meiramgul Akimbekovna Ibraimova,
Chief Expert of the Division for Technical Regulations on Food Products of the
Committee for Sanitary and Epidemiological Control of the Ministry of Healthcare
of the Republic of Kazakhstan.
The
foreign side was represented by:
·
Elmira Pistayeva — Senior Government Relations Adviser, Kazakhstan Foreign Investors’
Council Association;
·
Yaroslava Budach — Director of Research and Development, Polpharma Group;
·
Askhat Mubarakov — Market Access Manager, Khimpharm JSC (SANTO, a member of the
Polpharma Group).
The
meeting focused on improving the regulation of dietary supplements in
Kazakhstan, ensuring their safety and strengthening pharmacovigilance, as well
as addressing current issues related to product registration and amendments to
regulatory requirements. The parties also considered the possibility of holding
a roundtable with experts from the European Union to exchange international
experience in this area.
The
parties emphasised the importance of continued constructive dialogue between
government authorities and foreign businesses and expressed their commitment to
further cooperation and the promotion of responsible pharmacological practices
in accordance with the legislation of the Republic of Kazakhstan.